VERTINOC 16 TABLET is used for reducing the episodes of recurrent vertigo associated with Meniere’s disease. It contains Betahistine which belongs to the group of medicines called Antivertigo agents. It works by improving blood flow in the inner ear. This lowers the buildup of pressure.

Uses Of VERTINOC 16 TABLET

• It is used for reducing the episodes of recurrent vertigo associated with Meniere’s disease

How VERTINOC 16 TABLET Works

VERTINOC 16 TABLET is a histamine analogue with anti-motion sickness and vasodilating properties. It reduces the unpleasant symptoms of Meniere’s disease (such as nausea, dizziness, vertigo and tinnitus) by improving the blood supply to the inner ear.

How to use VERTINOC 16 TABLET

• Take VERTINOC 16 TABLET as advised by your physician. It can be taken with or without food
• For Tablets: Swallow the medicine with a glass of water. Do not crush or chew the medicine
• For Mouth Dissolving Tablet or Orally Disintegrating Tablet: Place the medicine inside your mouth and let it dissolve completely. Do not swallow or chew the medicine
• Your doctor will decide the correct dose and duration of therapy for you depending on your age, body weight and severity of the disease

Side Effects Of VERTINOC 16 TABLET

Common side effects of VERTINOC 16 TABLET:

• nausea
• indigestion, bloating, stomach pain
• headache

Stop taking VERTINOC 16 TABLET and contact your doctor immediately if you experience any of the following side effects:

• Severe allergic reactions (such as lumpy red skin rashes with itching, swelling of your face, lips, tongue or neck, drop in your blood pressure and difficulty in breathing)

Warning & Precautions

Pregnancy

Consult your doctor

Consult your doctor before taking VERTINOC 16 TABLET if you are a pregnant women.

Breastfeeding

Consult your doctor

Consult your doctor before taking VERTINOC 16 TABLET if you are a breastfeeding women.

Driving and Using Machines

Use with Caution

VERTINOC 16 TABLET does not affect your ability to drive or handle any heavy tools or machines.

Allergy

Contraindicated

Do not take VERTINOC 16 TABLET if you are allergic to Betahistine or any other ingredients of this medicine.

Lungs

Use with Caution

VERTINOC 16 TABLET should be used with caution in patients with asthma.

Use In Pediatrics

Contraindicated

VERTINOC 16 TABLET is not recommended for use in children and adolescents (aged below 18 years).

Use In Geriatrics

Use with Caution

VERTINOC 16 TABLET should be used with caution in elderly patients (aged above 75 years).

Interactions

A. Drug-Drug interactions:

• monoamine oxidase inhibitors (Ex. isocarboxazid, phenelzine, selegiline, tranylcypromine)

Overdosage:

If you or anyone else accidentally took more VERTINOC 16 TABLET, consult your doctor immediately or visit the nearby hospital. Symptoms of an overdose might include nausea, sleepiness, stomach pain, fast heartbeat, low blood pressure, shortness of breath with a feeling of suffocation (bronchospasm) an accumulation of fluids in the tissues (oedema) and fits.

Synopsis

More Information

FAQs About VERTINOC 16 TABLET

Q: What is VERTINOC 16 TABLET and why it is given?

A: VERTINOC 16 TABLET is an antivertigo agent used for reducing the episodes of recurrent vertigo associated with Meniere’s disease.

Q: Does VERTINOC 16 TABLET affects my ability to drive?

A: VERTINOC 16 TABLET does not affect your ability to drive or handle any heavy tools or machines. However, do not drive or operate any heavy tools or machines if you experience any unusual side effects.

Q: Can VERTINOC 16 TABLET cause stomach discomfort?

A: VERTINOC 16 TABLET may cause stomach discomfort, indigestion, bloating and nausea in a few individuals.

Q: Can VERTINOC 16 TABLET be used in pregnant or breastfeeding women?

A: Consult your doctor if you are a pregnant or a breastfeeding women before taking the medicine.

Q: What is the best time to take VERTINOC 16 TABLET?

A: Take VERTINOC 16 TABLET as directed by your physician. It must be taken after meals to avoid unwanted gastrointestinal disturbances. Your doctor will decide the correct dose, duration of therapy and time of administration for you depending on your age, body weight and disease condition.

Q: Does VERTINOC 16 TABLET control vertigo?

A: Yes. VERTINOC 16 TABLET is an antivertigo medicine with anti-motion sickness and vasodilating properties. It corrects vertigo by improving the blood supply to the inner ear that controls hearing, balance and posture.

Q: What are the side effects of VERTINOC 16 TABLET?

A: The most common side effects of taking VERTINOC 16 TABLET are headache, nausea and indigestion.  

Q: Who should not take VERTINOC 16 TABLET?

A: VERTINOC 16 TABLET should not be used in patients allergic to Betahistine. It is also not suitable for use in patients with vertigo and dizziness caused due to other head or brain problems apart from Meniere’s disease. It is not recommended for use in patients with phaeochromocytoma.

Q: Is VERTINOC 16 TABLET addictive in nature?

A: No. VERTINOC 16 TABLET is not addictive in nature.

Q: Can VERTINOC 16 TABLET be used in children?

A: VERTINOC 16 TABLET is not recommended for use in children and adolescents (aged below 18 years).

Q: Can I stop taking VERTINOC 16 TABLET once my symptoms subside?

A: Do not stop taking VERTINOC 16 TABLET without consulting your doctor even if you feel better during the midway of the therapy.

Q: What to do if I forgot to take a dose of VERTINOC 16 TABLET?

A: If you forgot to take a dose of VERTINOC 16 TABLET, take it as soon as you remember. However, if it is time for the next dose, skip the missed dose and take the next one regularly. Do not take a double dose to compensate for the missed ones.

References

1. K.D. Tripathi. Histamine and Anti-Histaminics. Essentials of medical pharmacology. Seventh edition. 2013. Page – 163.

2. Vladimir A. Parfenov, Volodymyr A. Golyk, Eduard I. Matsnev, Svetlana V. Morozova, Oleg A. Melnikov, Ludmila M. Antonenko, Elena E. Sigaleva, Maksym I. Situkho, Olena I. Asaulenko, Vasyl I. Popovych and Maxim V. Zamergrad. Effectiveness of betahistine (48 mg/day) in patients with vestibular vertigo during routine practice: The VIRTUOSO study. PLOS ONE. March 2017. [Accessed on 9th July 2024] click here

3. Jing Hui, Qi Lei, Zhi Ji and Dingjing Zi. Betahistine alleviates benign paroxysmal positional vertigo (BPPV) through inducing production of multiple CTRP family members and activating the ERK1/2-AKT/PPARy pathway. NIH. National Library of Medicine. National Center for Biotechnology Information. PMC. PubMed Central. April 2022. [Accessed on 9th July 2024] click here

4. Adrian James, Martin J Burton. Betahistine for Menière's disease or syndrome. NIH National Library of Medicine, National Centre for Biotechnology. PubMed Central. January 2001. [Accessed on 9th July 2024] click here

5. Milpharm Limited. Electronic Medicines Compendium (EMC). [Revised in January 2022] [Accessed on 9th July 2024] click here

6. Central Drugs Standard Control Organisation. Betahistine. [Accessed on 9th July 2024] click here

Author Details

Written By Srilekha. R - B.Pharm

Reviewed By Dr. Sankara Babu Gorle - MBBS, MD(Pharmacology) View profile

Last updated on 18 Nov 2024 | 12:33 PM(IST)